Sugi Predict

Sugi Predict / Compounds / SCHEMBL21723934

SCHEMBL21723934

SCHEMBL21723934

COc1ccc(-c2cc3c(s2)c(-c2ccc(C#N)cc2)cc(=O)n3C)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.42
▸ RAB9A P51151 4/20 0.42
▸ KDM4E B2RXH2 3/20 0.42
▸ PKM P14618 2/20 0.42
▸ MAPKAPK2 P49137 1/20 0.40
▸ GABRA1 P14867 1/20 0.40
▸ GABRG2 P18507 1/20 0.40
▸ GABRB3 P28472 1/20 0.40
▸ GABRA3 P34903 1/20 0.40
▸ GABRA2 P47869 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ HPGD P15428 3/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ PDPK1 O15530 1/20 0.39
▸ MAPT P10636 3/20 0.39
▸ APP P05067 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ STAT3 P40763 1/20 0.39
▸ MCHR1 Q99705 1/20 0.39
▸ GRIN1 Q05586 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21723987 0.91 NPC1 (0.48) NPC1RAB9AKDM4EPKMGABRA1
SCHEMBL21723639 0.86 HSD17B10 (0.47) NPC1RAB9AKDM4EPKMGABRA1
SCHEMBL21723905 0.82 PGR (0.39) KDM4EALDH1A1HPGDMAPTMCHR1
SCHEMBL21723952 0.81 GSK3B (0.41) NPC1RAB9AKDM4EPKMGABRA1
SCHEMBL21723989 0.78 NPC1 (0.48) NPC1RAB9AKDM4EPKMALDH1A1
SCHEMBL25259095 0.76 KDM4E (0.37) NPC1RAB9AKDM4EPKMGABRA1
SCHEMBL23452001 0.74 LMNA (0.43) NPC1RAB9AKDM4EPKMALDH1A1
SCHEMBL23451957 0.74 GABRG2 (0.46) NPC1RAB9AKDM4EPKMGABRA1
SCHEMBL25297318 0.71 NPC1 (0.40) NPC1RAB9AKDM4EALDH1A1HPGD
SCHEMBL21723705 0.71 NPC1 (0.51) NPC1RAB9AKDM4EPKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12415813-B2 Method for synthesizing thieno[3,2-b]pyridine-5(4H)-one derivative compound, using gold catalyst, and use therefor KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY (KR) 2025-09-16 — — US disclosed
US-20210332063-A1 METHOD FOR SYNTHESIZING THIENO[3,2-B]PYRIDINE-5(4H)-ONE DERIVATIVE COMPOUND, USING GOLD CATALYST, AND USE THEREFOR KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY (KP) 2021-10-28 — — US disclosed
US-20210332063-A1 METHOD FOR SYNTHESIZING THIENO[3,2-B]PYRIDINE-5(4H)-ONE DERIVATIVE COMPOUND, USING GOLD CATALYST, AND USE THEREFOR KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY (KP) 2021-10-28 — — US disclosed
WO-2020036243-A1 METHOD FOR SYNTHESIZING THIENO[3,2-B]PYRIDINE-5(4H)-ONE DERIVATIVE COMPOUND, USING GOLD CATALYST, AND USE THEREFOR 한국해양과학기술원 2020-02-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210332063-A1 METHOD FOR SYNTHESIZING THIENO[3,2-B]PYRIDINE-5(4H)-ONE DERIVATIVE COMPOUND, USING GOLD CATALYST, AND USE THEREFOR FARS2, CYP4F11, CYP4B1 NPC1 3352/4885RAB9A 3000/4885KDM4E 1113/4885
US-12415813-B2 Method for synthesizing thieno[3,2-b]pyridine-5(4H)-one derivative compound, using gold catalyst, and use therefor FARS2, CYP4F11, CYP4B1 NPC1 3352/4885RAB9A 3000/4885KDM4E 1113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.